A randomised, open-label, parallel, phase II trial evaluating the efficacy of aprepitant in patients with gynaecological cancer after postoperative adjuvant chemotherapy with paclitaxel and carboplatin

Trial Profile

A randomised, open-label, parallel, phase II trial evaluating the efficacy of aprepitant in patients with gynaecological cancer after postoperative adjuvant chemotherapy with paclitaxel and carboplatin

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Nov 2015

At a glance

  • Drugs Aprepitant (Primary) ; Dexamethasone; Dexamethasone; Serotonin 3 receptor antagonists
  • Indications Chemotherapy-induced nausea and vomiting
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top